Recruiting · registry status

Studying daily electromagnetic stimulation over a longer period

Researchers test the effects of daily pulsed electromagnetic stimulation applied to the brain in people with Parkinson’s.

Testing a treatment or activity · Study reference: NCT07306104

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported actual date): 2026-02-16
Main measurements finished (planned): 2028-01
Study finished (planned): 2028-01

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded

2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age 18 years and over · Also accepts healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Intervention Groups Inclusion Criteria: * Diagnosed with idiopathic Parkinson's disease * The participant must be able to understand, accept, and complete the planned procedures * Parkinson's symptoms in the medicated state must correspond to Hoehn \& Yahr stage 1 or 2 * Mini Mental-State Examination score \> 22 Exclusion Criteria: * Cancer in the brain, neck, or head area * Presence of active medical implants * Epilepsy * Alcoholism * Substance abuse * Open wound on the scalp * Severe psychopathological disorders * Pregnancy * Changes in pharmacological anti-Parkinson medication within the last 6 weeks prior to the start of T-PEMF treatment * Anticoagulant treatment with Marevan, Marcoumar, Pradaxa, Eliquis, Xarelto, Lixiana, Novostan, Fragmin, or Innohep * Neurological disease other than Parkinson's disease * Previous stroke * Reduced motor function caused by conditions other than Parkinson's disease Control Group with Parkinson's Disease Inclusion Criteria: * Diagnosed with idiopathic Parkinson's disease * The patient must be able to understand, accept, and complete the planned procedures * Parkinson's symptoms in the medicated state must correspond to Hoehn \& Yahr stage 1 or 2 * Mini Mental-State Examination score \> 22 Exclusion Criteria: * Neurological disease other than Parkinson's disease * Reduced motor function caused by conditions other than Parkinson's disease Healthy Reference Group: Inclusion Criteria: -The patient must be able to understand, accept, and complete the planned procedures Exclusion Criteria: * Neurological disease * Reduced motor function caused by condition

Full study name & original research details

Official study title

The Effect of Long-term Treatment of Parkinson's Disease With T-PEMF

Short title used by the registry

The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons Disease

Original description

The goal of this clinical trial is to learn to what extent daily stimulation of the brain with transcranial pulsed electromagnetic fields (T-PEMF) works to treat persons with Parkinson's Disease. The main questions it aims to answer are: * How does 6 months of daily treatment (30 minutes/day) with T-PEMF affects neuro-mechanical and molecular biological factors compared with placebo treatment in persons with Parkinson's disease? * How does 12 months of daily treatment (30 minutes/day) with T-PEMF affects neuro-mechanical and molecular biological factors in persons with Parkinson's disease an does 12 months of T-PEMF alters the need for medication intake? The neuro-mechanical outcomes are compared with the "natural" progression of the disease as well as with a healthy reference group. Furthermore, it will be examined whether 12 months of T-PEMF treatment alters the need for medication intake. Participants in the intervention group will: * receive one 30 min treatment session daily for 12 months * receive either T-PEMF or sham treatment for the first 6 months * receive active T-PEMF treatment the last 6 months * visit for tests before treatment initiation, after 6 months of treatment and after 12 months of treatment.

Conditions reported: PARKINSON DISEASE (Disorder)

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

ClinicalTrials.gov · NCT07306104 ↗ — RECRUITING; checked 2026-10-11
ClinicalTrials.gov · NCT07306104 ↗ — Recruiting; WHO ICTRP processed 2026-05-11; checked 2026-10-11

Study type: Interventional
Interventions: Transcranial pulsed electromagnetic fields (T-PEMF); Sham (No Treatment)
Phases: NA
Sponsor: University of Southern Denmark
Start date reported by registry: 2026-02-16 (actual)

Registry updated: 2026-04-29 · Status last verified by the registry submitter: 2026-04

Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Anne Sofie Bøgh Malling, Ph.d. · +45 28903733 · amalling@health.sdu.dk

Bente Rona Jensen, Professor · brjensen@health.sdu.dk

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Odense University Hospital

Odense, Denmark

Recruiting

Christian Winterberg, MD · +45 65411833 · christian.winterberg@rsyd.dk

Christian Winterberg, MD

University of Southern Denmark

Odense, Denmark

Recruiting

Anne Sofie Bøgh Malling, Ph.d. · +45 28903733 · amalling@health.sdu.dk

Jens Bojsen-Møller, Ass. proffessor · jbojsen@health.sdu.dk

Anne Sofie B Malling, Ph.d.

Mikkel C Juhl, MSc

Morten Meyer, Professor

Bente R Jensen, Professor

Jens Bojsen-Møller, Ass. Professor

Facility not reported

Denmark

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.